Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Avricore Health Inc. (V:AVCR)

Business Focus: Biopharmaceuticals

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for AVCR within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Feb 16, 2021 08:00 ET
Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce it has signed a Letter of Intent with Avrok Laboratories (Avrok), a CLIA certified laboratory in California, to offer COVID-19 screening to...
Read full article
Feb 12, 2021 08:30 ET
Avricore Health Completes $1.54 Million Financing and Grants Options
AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “Avricore”) announces it has closed its non-brokered private placement announced on February 3rd for gross proceeds of $1,540,000. The Company will issue 7,000,000 units at $0.22 per unit and will...
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
-3.07
--
--
Price to Sales - TTM
483.52
15.01
15.17
Price to Book - most recent quarter
--
7.93
4.43
Price to Cash Flow per share - TTM
--
--
15.66
Price to Free Cash Flow per share - TTM
--
--
28.14
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Feb 28, 2021880,230-1,663,472
Feb 15, 20212,543,7022,361,517
Jan 31, 2021182,185166,565
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Avricore Health Inc. is a Canada-based healthcare technology company. The Company distributes a technology platform, HealthTab, which consists of point of care screening devices and related supplies and training materials, along with a real-time data reporting networking. HealthTab is designed to offer a screening system within pharmacies to enable patients to be active about health by measuring and monitoring safety tests and biomarkers of chronic disease. Rapid Access Safety Test Reporting (RASTR), is a cloud-based network technology that enables the real-time response system to automatically report data to the consumer, healthcare team, and research entities through a Web-enabled blood chemistry analyzer, Piccolo Xpress.

See business summary

 

Twitter

Search (past week) for $AVCR.CA AVCR.V

  • No tweets found